Muon spin relaxation studies of incommensurate magnetism and superconductivity in stage-4 La2_{2}CuO4.11_{4.11} and La1.88_{1.88}Sr0.12_{0.12}CuO4_{4}

This paper reports muon spin relaxation (MuSR) measurements of two single crystals of the title high-Tc cuprate systems where static incommensurate magnetism and superconductivity coexist. By zero-field MuSR measurements and subsequent analyses with simulations, we show that (1) the maximum ordered Cu moment size (0.36 Bohr magneton) and local spin structure are identical to those in prototypical stripe spin systems with the 1/8 hole concentration; (2) the static magnetism is confined to less than a half of the volume of the sample, and (3) regions with static magnetism form nano-scale islands with the size comparable to the in-plane superconducting coherence length. By transverse-field MuSR measurements, we show that Tc of these systems is related to the superfluid density, in the same way as observed in cuprate systems without static magnetism. We discuss a heuristic model involving percolation of these nanoscale islands with static magnetism as a possible picture to reconcile heterogeneity found by the present MuSR study and long-range spin correlations found by neutron scattering.Comment: 19 pages, 15 figures, submitted to Phys. Rev. B. E-mail: [email protected]

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”

The current status of screening for gastric cancer-risk (gastritis A, B, C, D) method using combined assay for serum anti-Helicobacter pylori (Hp) IgG antibody and serum pepsinogen (PG) levels, “ABC method”, was reviewed and the latest results of our ongoing trial are reported. It was performed using the following strategy: Subjects were classified into 1 of 4 risk groups based on the results of the two serologic tests, anti-Hp IgG antibody titers and the PG I and II levels: Group A [Hp(−)PG(−)], infection-free subjects; Group B [Hp(+)PG(−)], chronic atrophic gastritis (CAG) free or mild; Group C [Hp(+)PG(+)], CAG; Group D [Hp(−)PG(+)]), severe CAG with extensive intestinal metaplasia. Continuous endoscopic follow-up examinations are required to detect early stages of gastric cancer. Asymptomatic Group A, which accounts for 50–80% of all the subjects may be excluded from the secondary endoscopic examination, from the viewpoint of efficiency. Hp-infected subjects should be administered eradication treatment aimed at the prevention of gastric cancer